Page last updated: 2024-10-25

chlorpropamide and Hemoglobinuria, Paroxysmal

chlorpropamide has been researched along with Hemoglobinuria, Paroxysmal in 1 studies

Chlorpropamide: A sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277)
chlorpropamide : An N-sulfonylurea that is urea in which a hydrogen attached to one of the nitrogens is substituted by 4-chlorobenzenesulfonyl group and a hydrogen attached to the other nitrogen is substituted by propyl group. Chlorpropamide is a hypoglycaemic agent used in the treatment of type 2 (non-insulin-dependent) diabetes mellitus not responding to dietary modification.

Hemoglobinuria, Paroxysmal: A condition characterized by the recurrence of HEMOGLOBINURIA caused by intravascular HEMOLYSIS. In cases occurring upon cold exposure (paroxysmal cold hemoglobinuria), usually after infections, there is a circulating antibody which is also a cold hemolysin. In cases occurring during or after sleep (paroxysmal nocturnal hemoglobinuria), the clonal hematopoietic stem cells exhibit a global deficiency of cell membrane proteins.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Logue, GL1
Boyd, AE1
Rosse, WF1

Other Studies

1 other study available for chlorpropamide and Hemoglobinuria, Paroxysmal

ArticleYear
Chlorpropamide-induced immune hemolytic anemia.
    The New England journal of medicine, 1970, Oct-22, Volume: 283, Issue:17

    Topics: Anemia, Hemolytic; Antibodies; Blood Transfusion; Chlorpropamide; Chromatography, DEAE-Cellulose; Ch

1970